The meaningful use provisions of the stimulus bill provide incentive payments to providers who implement EMRs, and ultimately penalties for those who don’t or who don’t use those systems in certain ways. A pair of new briefs outline challenges for providers to meet the meaningful use requirements.
The Office of Actuary publishes its current estimate of national health spending in the wake of health reform. It finds that the law will slightly increase spending, but there is a big caveat because the projections assume Medicare payment cuts will stay in place.
Fall is a lovely time of year and what could be better than relaxing with a Potpourri, featuring health insurance increases, the true costs of EHRs, hospital pay-for-performance programs and quality, the impact of social networks on health behavior, and unenrolled Medicaid-eligible children.
Medicaid programs, and other third-party payers, can save a lot of money by requiring use of generics when available. Some state laws, however, can significantly inhibit generic use, according to new research in Health Affairs.
In a sign that the media is less willing to accept some of the Administration’s misleading pronunciations about health care, when HHS claimed that the Medicare Trustee’s report showed the new health law extended Medicare solvency by several years, most sources noted that the CMS Actuary disagreed.
Every year Medicare puts out very lengthy and detailed proposed, and ultimately final, rules updating the reimbursement for all of the classes of providers–physicians, hospitals, etc. While reading these is a tough slog, it gives a good sense of issues which affect all payers, and of Medicare’s mindset.
There has been no more gnarly health care problem for Congress than how to deal with physician reimbursement. At some point, as a Health Affairs article points out, it will have to come up with a better solution than the temporary fixes it has used for years.
More commentary on MedPAC’s Annual Report, focusing on the care of dual-eligible beneficiaries and the use of shared decision-making in the Medicare population.
MedPAC’s annual report always contains many useful analyses of health care issues, complete with research citations. This year’s report covers several topics of general interest, including effective benefit designs and improving quality efforts.
For several decades drug companies have taken a beating over their pricing and many governments have limited how those companies charge for their products. A new study suggests that such regulation does limit development of new medicines.
HHS has issued its draft regulation on what preventive services health plans must cover without cost-sharing by the patient. Someone, of course, has to pay for all these “free” services, and it usually is the consumer.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
© 2024 Healthy Skeptic.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts